Concept
Trans fat
Related people (14)
Lyesse Laloui
Director, EPFL Soil Mechanics LaboratoryDirector, EPFL Civil Engineering SectionEditor in Chief, ElsevierMember of the Swiss Academy of Engineering SciencesFounding Partner, Geoeg & MeduSoilActive in academic research in the following institutions: Lausanne, EPFL, Durham, Duke University, Nanjing, Hohai UniversityProfessor Lyesse Laloui teaches at EPFL, where he directs the Soil Mechanics Laboratory as well as the Civil Engineering Section. He is a founding partner of the international engineering company Geoeg, and the start-up MeduSoil. In addition, he is an adjunct professor at Duke University, USA and an advisory professor at Hohai University, China as well as honorary director of the International Joint Research Center for Energy Geotechnics in China.He is the recipient of an Advance ERC grant for his BIO-mediated GEO-material Strengthening project. Editor in Chief of the Elsevier Geomechanics for Energy and the Environment journal, he is a leading scientist in the field of geomechanics and geo-energy. He has written and edited 13 books and published over 320 peer reviewed papers; his work is cited more than 6000 times with an h-index of 39 (Scopus). Two of his papers are among the top 1% in the academic field of Engineering. He has given keynote and invited lectures at more than 40 leading international conferences. He has received several international awards (IACMAG, RM Quigley, Roberval) and delivered honorary lectures (Vardoulakis, Minnesota; G.A. Leonards, Purdue; Kersten, Minnesota). He recently acted as the Chair of the international evaluation panel of Civil and Geological Engineering R&D Units of Portugal.Nov. 2019 For further information visit www.epfl.ch/labs/lms/ ; geoeg.net ; medusoil.com
Johan Auwerx
Johan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Rolf Gruetter
Awards:
1999 Young Investigator Award Plenary Lectureship
, International Society for Neurochemistry
2011 Fellow
, ESMRMB
2011 Teaching Award
, Section Sciences de la Vie, EPFL